Compare Jayamas Medica Industri Tbk. (OMED) vs Solusi Bangun Indonesia Tbk. (SMCB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jayamas Medica Industri Tbk. vs Solusi Bangun Indonesia Tbk. — how do they compare? Jayamas Medica Industri Tbk. trades at Rp214 (market cap 5.79T, 9.53M 24h volume), while Solusi Bangun Indonesia Tbk. trades at Rp775 (market cap 6.99T). The key difference: Solusi Bangun Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| OMED | SMCB | |
|---|---|---|
Market Cap | 5.79T | 6.99T |
Volume | 9.53M | — |
Lot | 95.3K | — |
Turnover | 2.05B | — |
Average Price | 215.03 | — |
Value | 2.05B | — |
Indicative Equilibrium Price | 214 | — |
Indicative Equilibrium Volume | 1.69K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jayamas Medica Industri Tbk.
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →About Solusi Bangun Indonesia Tbk.
PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Read more on SMCB →
